- Home
- SIGA vs ALT Comparison
SIGA vs ALT Comparison
Compare SIGA & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGA
- ALT
- Stock Information
- Founded
- SIGA 1995
- ALT 1997
- Country
- SIGA United States
- ALT United States
- Employees
- SIGA N/A
- ALT N/A
- Industry
- SIGA Biotechnology: Pharmaceutical Preparations
- ALT Biotechnology: Pharmaceutical Preparations
- Sector
- SIGA Health Care
- ALT Health Care
- Exchange
- SIGA Nasdaq
- ALT Nasdaq
- Market Cap
- SIGA N/A
- ALT 472.3M
- IPO Year
- SIGA 1997
- ALT N/A
- Fundamental
- Price
- SIGA $5.49
- ALT $4.86
- Analyst Decision
- SIGA
- ALT Strong Buy
- Analyst Count
- SIGA 0
- ALT 8
- Target Price
- SIGA N/A
- ALT $21.00
- AVG Volume (30 Days)
- SIGA 441.3K
- ALT 3.0M
- Earning Date
- SIGA 03-11-2025
- ALT 05-08-2025
- Dividend Yield
- SIGA 10.95%
- ALT N/A
- EPS Growth
- SIGA N/A
- ALT N/A
- EPS
- SIGA 0.82
- ALT N/A
- Revenue
- SIGA $138,719,350.00
- ALT $20,000.00
- Revenue This Year
- SIGA $35.56
- ALT N/A
- Revenue Next Year
- SIGA N/A
- ALT N/A
- P/E Ratio
- SIGA $6.68
- ALT N/A
- Revenue Growth
- SIGA N/A
- ALT N/A
- 52 Week Low
- SIGA $5.16
- ALT $4.78
- 52 Week High
- SIGA $12.83
- ALT $11.16
- Technical
- Relative Strength Index (RSI)
- SIGA 42.19
- ALT 32.99
- Support Level
- SIGA $5.55
- ALT $4.78
- Resistance Level
- SIGA $6.04
- ALT $6.16
- Average True Range (ATR)
- SIGA 0.24
- ALT 0.34
- MACD
- SIGA -0.01
- ALT -0.05
- Stochastic Oscillator
- SIGA 14.49
- ALT 2.54
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.